Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9,173 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy of Preventing Relapse Evaluated by a Multicenter Randomized Double-Blind Placebo-Controlled Withdrawal Study of Escitalopram in Japanese Adolescents with Major Depressive Disorder.
Saito T, Takahashi H, Tsujii N, Sasaki T, Yamaguchi Y, Takatsu M, Sato M. Saito T, et al. Among authors: sasaki t. J Child Adolesc Psychopharmacol. 2023 Dec;33(10):418-427. doi: 10.1089/cap.2023.0048. Epub 2023 Dec 7. J Child Adolesc Psychopharmacol. 2023. PMID: 38055198 Free PMC article. Clinical Trial.
Trajectories of Healthcare Utilization Among Children and Adolescents With Autism Spectrum Disorder and/or Attention-Deficit/Hyperactivity Disorder in Japan.
Aoki A, Niimura M, Kato T, Takehara K, Iida J, Okada T, Kurokami T, Nishimaki K, Ogura K, Okuno M, Koeda T, Igarashi T; Collaborative Working Group. Aoki A, et al. Front Psychiatry. 2022 Jan 20;12:812347. doi: 10.3389/fpsyt.2021.812347. eCollection 2021. Front Psychiatry. 2022. PMID: 35126213 Free PMC article.
Study of effects of ifenprodil in patients with methamphetamine dependence: Protocol for an exploratory, randomized, double-blind, placebo-controlled trial.
Kotajima-Murakami H, Takano A, Ogai Y, Tsukamoto S, Murakami M, Funada D, Tanibuchi Y, Tachimori H, Maruo K, Sasaki T, Matsumoto T, Ikeda K. Kotajima-Murakami H, et al. Among authors: sasaki t. Neuropsychopharmacol Rep. 2019 Jun;39(2):90-99. doi: 10.1002/npr2.12050. Epub 2019 Feb 12. Neuropsychopharmacol Rep. 2019. PMID: 30756527 Free PMC article. Clinical Trial.
Ifenprodil for the treatment of methamphetamine use disorder: An exploratory, randomized, double-blind, placebo-controlled trial.
Kotajima-Murakami H, Takano A, Hirakawa S, Ogai Y, Funada D, Tanibuchi Y, Ban E, Kikuchi M, Tachimori H, Maruo K, Kawashima T, Tomo Y, Sasaki T, Oi H, Matsumoto T, Ikeda K. Kotajima-Murakami H, et al. Among authors: sasaki t. Neuropsychopharmacol Rep. 2022 Mar;42(1):92-104. doi: 10.1002/npr2.12232. Epub 2022 Jan 23. Neuropsychopharmacol Rep. 2022. PMID: 35068087 Free PMC article. Clinical Trial.
Effects of the combination of atomoxetine and oxybutynin in Japanese patients with obstructive sleep apnoea: A randomized controlled crossover trial.
Kinouchi T, Terada J, Sakao S, Koshikawa K, Sasaki T, Sugiyama A, Sato S, Sakuma N, Abe M, Shikano K, Hayama N, Shiko Y, Ozawa Y, Ikeda S, Suzuki T, Tatsumi K. Kinouchi T, et al. Among authors: sasaki t. Respirology. 2023 Mar;28(3):273-280. doi: 10.1111/resp.14383. Epub 2022 Oct 2. Respirology. 2023. PMID: 36184258 Clinical Trial.
The effectiveness of very slow switching to aripiprazole in schizophrenia patients with dopamine supersensitivity psychosis: a case series from an open study.
Kanahara N, Takase M, Sasaki T, Honma M, Fujita Y, Tadokoro S, Suzuki H, Yamanaka H, Noda S, Yanahashi S, Saiga T, Komatsu N, Simoyama T, Iyo M. Kanahara N, et al. Among authors: sasaki t. Int Clin Psychopharmacol. 2020 Nov;35(6):338-344. doi: 10.1097/YIC.0000000000000322. Int Clin Psychopharmacol. 2020. PMID: 32868522 Clinical Trial.
9,173 results